In a multivariate model, the PNPLA3 GG and TM6SF2 CT + TT genotypes were, respectively, associated with a 14.9- and 3.1-fold increased risk of having NAFLD (data not shown). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.